Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INMD · against 491 other Healthcare companies of similar size
Ranked #130 of 492 · scores higher than 74% of peers · safety percentile 77
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)56 peers with a safety percentile of 70–79, including INMD · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | INMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 461 reported | 0.01× | 0.18× | 89% | 33% | |
| BetaLower is better · 469 reported | 1.86 | 0.42 | 4% | 33% | |
| Current ratioHigher is better · 485 reported | 8.18× | 2.79× | 83% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 421M USD | 99 | 52 | |
| 126 | 15.7B TWD (≈$485M) | 78 | 43 | |
| 127 | 479M USD | 78 | 34 | |
| 128 | 3.6B CNY (≈$506M) | 78 | 65 | |
| 129 | 7.1B CNY (≈$993M) | 78 | 27 | |
| 130 | 810M USD | 77 | 69 | |
| 131 | 10.5B CNY (≈$1.5B) | 77 | 66 | |
| 132 | 11.2B CNY (≈$1.6B) | 77 | 61 | |
| 133 | 5.5B CNY (≈$764M) | 77 | 43 | |
| 134 | 3.2B CNY (≈$452M) | 77 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score